Embecta AID System in Adults With Type 2 Diabetes

Withdrawn before enrolling · Not applicable

Conditions studied: Type 2 Diabetes, Type 2 Diabetes Mellitus (T2DM), Type 2 DM, T2DM With Inadequate Glycemic Control, T2DM (Type 2 Diabetes Mellitus), T2D, T2DM

In brief

This is a multi-center, randomized control study that will evaluate the safety and effectiveness of the embecta Automated Insulin Delivery System in adults with Type 2 diabetes requiring insulin therapy

Key facts

Study ID

NCT06692153

Run by

Embecta Corp.

People needed

0

Starts

2025-01-01

Expected to finish

2026-05-01

Last updated by the study team

2024-12-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Stanford — Palo Alto, California, United States
• Diablo Research — Walnut Creek, California, United States
• Indiana Universtiy School of Medicine — Indianapolis, Indiana, United States
• NYC Research — Long Island City, New York, United States
• Icahn School of Medicine at Mt. Sinai — New York, New York, United States
• UT Southwestern — Dallas, Texas, United States
• Tekton Research — Irving, Texas, United States
• Texas Diabetes & Endocrinology — Round Rock, Texas, United States
• DETS Utah — Sandy City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.